Artificial Intelligence Used in Screening Adrenal Nodules
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPeking University First Hospital
About this trial
By collecting chest low-dose spiral CT plain scan images, extracting effective features from the adrenal gland regions, training and validating an artificial intelligence-based automatic diagnostic algorithm for adrenal nodules, we will ultimately develop an artificial intelligence software with independent intellectual property rights that is specifically designed for screening adrenal nodules in chest low-dose CT scans.
Eligibility criteria
Qualifiers
The age of the population is over 18 years old, regardless of gender;
Images from chest low-dose CT plain scan during routine physical examination;
Disqualifiers
Patients with a history of malignant tumors;
Imaging images with poor quality, artifacts, etc., which make analysis impossible.
Trial design
Treatments tested in this trial
- None intervention
Treatment groups
600 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov